SG11201508448RA - Heterocyclic acetamide compound - Google Patents
Heterocyclic acetamide compoundInfo
- Publication number
- SG11201508448RA SG11201508448RA SG11201508448RA SG11201508448RA SG11201508448RA SG 11201508448R A SG11201508448R A SG 11201508448RA SG 11201508448R A SG11201508448R A SG 11201508448RA SG 11201508448R A SG11201508448R A SG 11201508448RA SG 11201508448R A SG11201508448R A SG 11201508448RA
- Authority
- SG
- Singapore
- Prior art keywords
- acetamide compound
- heterocyclic
- heterocyclic acetamide
- compound
- acetamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013087151 | 2013-04-18 | ||
| PCT/JP2014/061007 WO2014171528A1 (ja) | 2013-04-18 | 2014-04-18 | ヘテロ環酢酸アミド化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201508448RA true SG11201508448RA (en) | 2015-11-27 |
Family
ID=51729480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201508448RA SG11201508448RA (en) | 2013-04-18 | 2014-04-18 | Heterocyclic acetamide compound |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US8937087B2 (ko) |
| EP (1) | EP2987793B1 (ko) |
| JP (1) | JP6252582B2 (ko) |
| KR (1) | KR102193247B1 (ko) |
| CN (1) | CN105121435B (ko) |
| AR (1) | AR095883A1 (ko) |
| AU (1) | AU2014254768B2 (ko) |
| BR (1) | BR112015026512B1 (ko) |
| CA (1) | CA2909783C (ko) |
| CY (1) | CY1119754T1 (ko) |
| DK (1) | DK2987793T3 (ko) |
| EA (1) | EA028968B1 (ko) |
| ES (1) | ES2651866T3 (ko) |
| HK (1) | HK1214248A1 (ko) |
| HR (1) | HRP20171786T1 (ko) |
| HU (1) | HUE036054T2 (ko) |
| IL (1) | IL241962B (ko) |
| LT (1) | LT2987793T (ko) |
| ME (1) | ME02891B (ko) |
| MX (1) | MX2015014646A (ko) |
| MY (1) | MY175971A (ko) |
| NO (1) | NO2987793T3 (ko) |
| NZ (1) | NZ713118A (ko) |
| PH (1) | PH12015502341A1 (ko) |
| PL (1) | PL2987793T3 (ko) |
| PT (1) | PT2987793T (ko) |
| RS (1) | RS56865B1 (ko) |
| SA (1) | SA515370015B1 (ko) |
| SG (1) | SG11201508448RA (ko) |
| SI (1) | SI2987793T1 (ko) |
| TW (1) | TWI625329B (ko) |
| UA (1) | UA116243C2 (ko) |
| WO (1) | WO2014171528A1 (ko) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR105025A1 (es) | 2015-06-19 | 2017-08-30 | Astellas Pharma Inc | Compuesto de imidazodiazepina |
| TWI725408B (zh) | 2018-04-20 | 2021-04-21 | 美商美國禮來大藥廠 | 多巴胺d1受體正向異位調節劑 |
| WO2020053282A1 (de) | 2018-09-13 | 2020-03-19 | Bayer Aktiengesellschaft | Heterocyclen-derivate als schädlingsbekämpfungsmittel |
| CN110590576A (zh) * | 2019-08-15 | 2019-12-20 | 安徽金禾实业股份有限公司 | 一种4-多氟代甲氧基邻苯二胺的制备方法 |
| CN114380709B (zh) * | 2021-12-31 | 2023-07-21 | 西北农林科技大学 | 4-氯-2-酰氨基酚的合成方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2674524B1 (fr) * | 1991-03-25 | 1993-05-21 | Adir | Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| AU4058000A (en) | 1999-04-02 | 2000-10-23 | Neurogen Corporation | Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulatorsof gabaa receptors |
| US6627624B1 (en) | 1999-04-02 | 2003-09-30 | Neurogen Corporation | Aryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors |
| US6380210B1 (en) | 1999-04-02 | 2002-04-30 | Neurogen Corporation | Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors |
| AUPQ309399A0 (en) | 1999-09-28 | 1999-10-21 | Fujisawa Pharmaceutical Co., Ltd. | Benzothiazoline derivatives |
| JP2005508907A (ja) | 2001-09-14 | 2005-04-07 | ノボ ノルディスク アクティーゼルスカブ | ヒスタミンｈ３受容体に選択的に結合する置換されたピペリジン |
| US7361671B2 (en) | 2001-11-15 | 2008-04-22 | The Institute For Pharmaceutical Discovery, Inc. | Substituted heteroarylalkanoic acids |
| ATE486842T1 (de) | 2002-03-12 | 2010-11-15 | Merck Sharp & Dohme | Substituierte amide |
| JP4673294B2 (ja) | 2003-03-14 | 2011-04-20 | メルク・シャープ・エンド・ドーム・コーポレイション | 二環式アニリドスピロヒダントインｃｇｒｐ受容体拮抗物質 |
| EP1719761A4 (en) * | 2004-02-23 | 2007-10-10 | Dainippon Sumitomo Pharma Co | NEW HETEROCYCLIC CONNECTION |
| JP4914346B2 (ja) | 2004-05-27 | 2012-04-11 | ユセベ ファルマ ソシエテ アノニム | ベンズオキサゾロン誘導体、その調製方法及びその使用 |
| US7790726B2 (en) | 2005-08-16 | 2010-09-07 | Chemocentryx, Inc. | Monocyclic and bicyclic compounds and methods of use |
| US7576218B2 (en) | 2005-10-11 | 2009-08-18 | Chemocentryx, Inc. | 4-phenylpiperdine-pyrazole CCR1 antagonists |
| CL2007002097A1 (es) | 2006-07-20 | 2008-01-18 | Smithkline Beecham Corp | Compuestos derivados de pirrolidina o morfolina antagonistas de urotensina ii; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar insuficiencia cardiaca congestiva, insuficiencia cardiaca isquemica, angina, isquemia del miocardio, vejiga hiperactiva, asma y/o copd, entre otras. |
| US7786157B2 (en) | 2007-03-16 | 2010-08-31 | Chemocentryx, Inc. | OXO-imidazolidines as modulators of chemokine receptors |
| DE102007026341A1 (de) | 2007-06-06 | 2008-12-11 | Merck Patent Gmbh | Benzoxazolonderivate |
| GB0713686D0 (en) * | 2007-07-13 | 2007-08-22 | Addex Pharmaceuticals Sa | New compounds 2 |
-
2014
- 2014-04-16 AR ARP140101624A patent/AR095883A1/es active IP Right Grant
- 2014-04-17 TW TW103114022A patent/TWI625329B/zh active
- 2014-04-18 JP JP2015512531A patent/JP6252582B2/ja active Active
- 2014-04-18 PT PT147861157T patent/PT2987793T/pt unknown
- 2014-04-18 CN CN201480020846.XA patent/CN105121435B/zh active Active
- 2014-04-18 MY MYPI2015703694A patent/MY175971A/en unknown
- 2014-04-18 PL PL14786115T patent/PL2987793T3/pl unknown
- 2014-04-18 NZ NZ713118A patent/NZ713118A/en unknown
- 2014-04-18 EP EP14786115.7A patent/EP2987793B1/en active Active
- 2014-04-18 NO NO14786115A patent/NO2987793T3/no unknown
- 2014-04-18 MX MX2015014646A patent/MX2015014646A/es active IP Right Grant
- 2014-04-18 HU HUE14786115A patent/HUE036054T2/hu unknown
- 2014-04-18 UA UAA201511337A patent/UA116243C2/uk unknown
- 2014-04-18 LT LTEP14786115.7T patent/LT2987793T/lt unknown
- 2014-04-18 ME MEP-2017-277A patent/ME02891B/me unknown
- 2014-04-18 AU AU2014254768A patent/AU2014254768B2/en active Active
- 2014-04-18 KR KR1020157027691A patent/KR102193247B1/ko active IP Right Grant
- 2014-04-18 BR BR112015026512-0A patent/BR112015026512B1/pt active IP Right Grant
- 2014-04-18 RS RS20171324A patent/RS56865B1/sr unknown
- 2014-04-18 DK DK14786115.7T patent/DK2987793T3/en active
- 2014-04-18 EA EA201591988A patent/EA028968B1/ru not_active IP Right Cessation
- 2014-04-18 WO PCT/JP2014/061007 patent/WO2014171528A1/ja active Application Filing
- 2014-04-18 SG SG11201508448RA patent/SG11201508448RA/en unknown
- 2014-04-18 SI SI201430479T patent/SI2987793T1/en unknown
- 2014-04-18 ES ES14786115.7T patent/ES2651866T3/es active Active
- 2014-04-18 US US14/256,135 patent/US8937087B2/en active Active
- 2014-04-18 CA CA2909783A patent/CA2909783C/en active Active
- 2014-10-28 US US14/525,982 patent/US9708307B2/en active Active
-
2015
- 2015-10-07 IL IL241962A patent/IL241962B/en active IP Right Grant
- 2015-10-08 PH PH12015502341A patent/PH12015502341A1/en unknown
- 2015-10-18 SA SA515370015A patent/SA515370015B1/ar unknown
-
2016
- 2016-02-23 HK HK16102028.4A patent/HK1214248A1/zh unknown
-
2017
- 2017-11-17 HR HRP20171786TT patent/HRP20171786T1/hr unknown
- 2017-12-06 CY CY20171101288T patent/CY1119754T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20181392T1 (hr) | Heterociklični spojevi i njihova uporaba | |
| HK1223351A1 (zh) | 嘧啶衍生物作為激酶抑制劑 | |
| ZA201602220B (en) | Heterocyclic compounds and uses thereof | |
| HK1218512A1 (zh) | 雜環化合物和其用途 | |
| EP2982666A4 (en) | HETEROCYCLIC COMPOUND | |
| HK1221465A1 (zh) | 新型雜環化合物 | |
| EP3018126A4 (en) | HETEROCYCLIC COMPOUND | |
| EP3006444A4 (en) | HETEROCYCLIC AMIDE COMPOUND | |
| HK1220363A1 (zh) | 雜環化合物及其用途 | |
| EP2980089A4 (en) | HETEROCYCLIC CONNECTION | |
| HRP20190133T1 (hr) | Heterociklički spoj | |
| EP2982670A4 (en) | HETEROCYCLIC COMPOUND | |
| IL241962B (en) | Heterocyclic acetamide compound |